Search

Your search keyword '"Demidenko, Eugene"' showing total 659 results

Search Constraints

Start Over You searched for: Author "Demidenko, Eugene" Remove constraint Author: "Demidenko, Eugene"
659 results on '"Demidenko, Eugene"'

Search Results

2. AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells.

3. Laplace’s law of succession estimator and M-statistics.

16. Supplementary Figure S7 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer

17. Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer

18. Data from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer

19. Enhancement of Radiation Therapy through Blockade of the Immune Checkpoint, V-domain Ig Suppressor of T Cell Activation (VISTA), in Melanoma and Adenocarcinoma Murine Models

20. Enhancement of Adiation Therapy through Blockade of the Immune Checkpoint VISTA in Melanoma and Adenocarcinoma Murine Models

21. Supplementary Fig. 1 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer

22. Supplementary Methods 1 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer

23. Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer

24. Data from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer

29. Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer

30. Alternating 17beta-estradiol and aromatase inhibitor therapies is efficacious in post-menopausal women with advanced endocrine-resistant ER+ breast cancer

34. Enhancing sparse representation of color images by cross channel transformation

35. Supplementary Tables from A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition

36. Supplementary Data from A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition

37. Legend for Table S1 from AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells

39. Supplementary Table S1 from AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells

40. Supplementary Figures from AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells

41. Suppl Methods and References from AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells

42. Supplementary data from Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA-Mutant Breast Cancer

43. Supplementary Figure 1 from Blockade of the Ubiquitin Protease UBP43 Destabilizes Transcription Factor PML/RARα and Inhibits the Growth of Acute Promyelocytic Leukemia

44. Data from Blockade of the Ubiquitin Protease UBP43 Destabilizes Transcription Factor PML/RARα and Inhibits the Growth of Acute Promyelocytic Leukemia

45. Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer

48. Kolmogorov-Smirnov Test for Image Comparison

Catalog

Books, media, physical & digital resources